Meet Our Speakers
Our Featured Speakers for the 2026 Conference
We are pleased to welcome a distinguished line-up of local and international speakers to the 2026 CHF Cardiovascular Conference, each bringing deep expertise and valuable insights into cardiovascular health.
Learn more about our speakers below.
Additional speakers will be announced, so please continue to check back for updates.
View the 2026 Conference schedule here.
Bradley S. Taylor, M.D., MPH
Chief Medical Executive
Christine E. Lynn Heart & Vascular Institute
Chief of Cardiac Surgery, Palm Beach Region
Chief of Quality and Outcomes
Baptist Health Heart & Vascular Care
Baptist Health International (2026 PLATINUM SPONSOR)
Presentation title: Lifelong Management of the Thoracic Aorta: How to Refer, When to Act, and How to Align Imaging and Surveillance
ABOUT DR. BRAD TAYLOR
Bradley S. Taylor, M.D., is chief medical executive of Christine E. Lynn Heart & Vascular Institute, as well as chief of cardiac surgery for the Palm Beach Region and chief of quality and outcomes for Baptist Health Heart & Vascular Care. A board-certified cardiac surgeon, Dr. Taylor has more than 23 years of experience across all areas of adult cardiac surgery and treats more than 450 complex cardiac cases per year.
Dr. Taylor earned his medical degree and a master’s degree in public health from Emory University School of Medicine in Atlanta, Georgia. He completed a general surgery residency and a cardiothoracic surgery residency at University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania, as well as a minimally invasive cardiac surgery fellowship at Onze-Lieve-Vrouw Hospital (OLV Hospital) in Aalst, Belgium.
Prior to joining Baptist Health, Dr. Taylor was an endowed professor and chief of the Division of Cardiac Surgery at University of Maryland School of Medicine in Baltimore, Maryland. He also served as director of quality, director of coronary revascularization, and co-director of the Center for Aortic Disease at the University of Maryland Medical Center in Baltimore, Maryland.
Dr. Taylor’s clinical and research efforts have focused on robotic cardiac surgery, hybrid coronary revascularization, valvular heart disease, and endovascular and open repair of aortic dissections and aneurysms. He is considered an expert in cardiac surgery and has authored more than 125 peer-reviewed articles in numerous medical journals. He has also presented his findings at scientific symposiums.
As a clinical educator and member of several professional organizations, Dr. Taylor is committed to advancing clinical excellence in cardiac surgery, promoting clinical and basic science research, and training the next generation of physicians through residency and fellowship programs.
Sheng Fu, M.D.
Advanced Heart Failure and Transplant Cardiologist, Baptist Health Miami Cardiac & Vascular Institute
Baptist Health International (2026 PLATINUM SPONSOR)
ABOUT DR. SHENG FU
Sheng Fu, M.D., is a cardiologist specializing in advanced heart failure and transplantation at Baptist Health Miami Cardiac & Vascular Institute. His areas of expertise include cardiogenic shock, transplant cardiology and mechanical circulatory support. Dr. Fu is certified by the National Board of Echocardiography and holds certifications from the American Board of Internal Medicine in cardiovascular disease, advanced heart failure and transplantation, and internal medicine.
Dr. Fu earned his medical degree from the University of Toledo College of Medicine and Life Sciences in Toledo, Ohio, after earning a bachelor’s degree in neuroscience from Johns Hopkins University in Baltimore, Maryland. He completed an internal medicine residency at MetroHealth Medical Center, Case Western Reserve University in Cleveland, Ohio. His clinical training also includes a fellowship in cardiovascular disease at Allegheny General Hospital in Pittsburgh, Pennsylvania, and a fellowship in advanced heart failure and transplantation at the Medical University of South Carolina in Charleston, South Carolina.
Prior to joining Baptist Health, Dr. Fu served as an assistant professor of medicine at University of Louisville in Louisville, Kentucky. He also served as medical director of the Cardiac Intensive Care Unit and as associate medical director of heart transplantation at Jewish Hospital, University of Louisville in Louisville, Kentucky.
Dr. Fu has published extensively on heart failure, heart transplantation and mechanical circulatory support, with work featured in leading scientific journals, including Circulation: Heart Failure, JACC Case Reports and Journal of Cardiac Failure.
Dr. Fu is fluent in English and Mandarin Chinese.
Steven Bibevski, M.D., PhD
Pediatric Cardiac Surgery, Congenital Heart Surgery, Joe DiMaggio Children’s Hospital
Memorial Healthcare System (2026 SILVER PLUS SPONSOR)
Presentation title: Support of the infant and young child with ventricular assist devices.
Please confirm the time of the lecture.
ABOUT DR. STEVEN BIBEVSKI
Dr. Steven Bibevski comes to Joe DiMaggio Children’s Hospital from the University of Michigan, where he completed fellowships in both adult and pediatric cardiac surgery. His training at one of the busiest congenital heart programs in the nation, with more than 900 procedures annually, afforded him extensive experience in the treatment of all complex forms of congenital heart disease, with an emphasis on hypoplastic left heart syndrome. Originally from Melbourne, Australia, Dr. Bibevski also completed a visiting fellowship at the Royal Children’s Hospital in Melbourne, the largest pediatric heart center in the southern hemisphere. At both centers, Dr Bibevski developed extensive experience in managing all aspects of congenital heart disease.
Dr. Bibevski also has a strong research background. He obtained his PhD in cardiovascular physiology from Case Western Reserve University in Cleveland, Ohio, where he conducted research in the field of autonomic neural control of the cardiovascular system in heart failure. His research now focuses on developing biological valve replacement options for children as well as outcomes focused research in the field of congenital cardiac surgery.
Yiannis S. Chatzizisis, M.D., MSc, PhD, FACC, FAHA, FSCAI
Professor and Chief Director Division of Cardiovascular Medicine Center for Digital Cardiovascular Innovations
Atherosclerosis Associate Editor, University of Miami Health System, University of Miami Leonard M. Miller School of Medicine
UHealth International (2026 SILVER PLUS SPONSOR)
Presentation title: Role of Cardiac CT in CAD
ABOUT DR. YIANNIS S. CHATZIZISIS
Yiannis S. Chatzizisis, MD, PhD is Professor of Cardiology, and Chief of the Cardiovascular Division at the Miller School of Medicine, University of Miami. He was trained in interventional cardiology and advanced non-invasive cardiovascular imaging at the Brigham and Women’s Hospital. His translational and clinical research is actively funded by the NIH, industry, and philanthropy (collectively $6 million over the last 6 years).
He has authored more than 170 manuscripts published in Circulation, JACC, ATVB, Cardiovascular Research and Atherosclerosis among other journals. His research has received over 8,500 citations with an H-index of 43. He has received more than 40 international and national awards, including awards by the European Society of Cardiology, European Atherosclerosis Society, American Heart Association and Academy of Athens. In 2021 he received the “Bifurcation Person of the Year” award by the European Bifurcation Club.
He serves as Associate Editor for Atherosclerosis, and Pharmacology and Therapeutics, and as manuscript reviewer for JACC and Circulation family journals among others. He is member NIH and DOD study sections. He serves as industry advisory board member and consultant on coronary stents, intracoronary imaging, and physiology.
He is Fellow of ACC, AHA, SCAI and ESC, Member of the Board of Directors of the European Bifurcation Club and founding Member of the SCAI Bifurcation Club. Over the years, he has mentored many general cardiology, interventional cardiology, imaging and research fellows and faculty, who are now independent investigators, faculty, or trainees in renowned institutions in the U.S. and Europe.